HGH FRAG 176-191

HGH Fragment 176–191 – Specialized Growth Hormone Sequence for Metabolic and Lipolytic Research

Overview:
HGH Fragment 176–191 is a synthetic peptide segment of human growth hormone (hGH) extensively studied in metabolic, mitochondrial, and adipose tissue research. This isolated fragment represents the C-terminal portion of the GH molecule, engineered for targeted receptor interactions that promote lipolytic and energy-regulating pathways without the full hormonal activity of native GH.

Used in controlled laboratory settings, HGH Frag 176–191 supports investigations into fat metabolism, energy balance, and biochemical mechanisms related to growth hormone–mediated cellular processes.

Scientific Background:
Research indicates that HGH Fragment 176–191 activates adenylate cyclase and cAMP-dependent signaling in adipocytes, leading to enhanced lipolytic enzyme expression and reduced lipid accumulation.
By isolating this active sequence, scientists can explore GH receptor selectivity, metabolic modulation, and energy substrate utilization with greater precision and without systemic endocrine influence.

This makes HGH Frag 176–191 an important model in biochemical, metabolic, and mitochondrial studies focused on energy expenditure and lipid oxidation.

Why Researchers Study HGH Fragment 176–191:
HGH Frag 176–191 offers a focused research model for studying the metabolic pathways and biochemical specificity of growth hormone fragments. Its structure and receptor selectivity make it ideal for non-anabolic GH research, supporting investigations into lipolysis, energy signaling, and targeted peptide activity.

? For Laboratory Research Use Only. Not for Human or Veterinary Use. Not for Human Consumption.